Mycoplasma genitalium infection

BMJ. 2019 Oct 18:367:l5820. doi: 10.1136/bmj.l5820.
No abstract available

MeSH terms

  • Aftercare / methods
  • Aftercare / standards
  • Anti-Bacterial Agents / standards
  • Anti-Bacterial Agents / therapeutic use*
  • Asymptomatic Infections / epidemiology
  • Asymptomatic Infections / therapy
  • DNA, Bacterial / isolation & purification
  • Female
  • Humans
  • Male
  • Mass Screening / methods
  • Mass Screening / standards
  • Mycoplasma Infections / diagnosis*
  • Mycoplasma Infections / epidemiology
  • Mycoplasma Infections / microbiology
  • Mycoplasma Infections / therapy
  • Mycoplasma genitalium / genetics
  • Mycoplasma genitalium / isolation & purification*
  • Pelvic Inflammatory Disease / diagnosis*
  • Pelvic Inflammatory Disease / epidemiology
  • Pelvic Inflammatory Disease / microbiology
  • Pelvic Inflammatory Disease / therapy
  • Practice Guidelines as Topic
  • Prevalence
  • Risk Factors
  • Sexually Transmitted Diseases, Bacterial / diagnosis*
  • Sexually Transmitted Diseases, Bacterial / epidemiology
  • Sexually Transmitted Diseases, Bacterial / microbiology
  • Sexually Transmitted Diseases, Bacterial / therapy
  • Urethritis / diagnosis*
  • Urethritis / epidemiology
  • Urethritis / microbiology
  • Urethritis / therapy

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial